The Online Investor
Healthcare IPOs image Healthcare IPOs » By The Online Investor Staff, updated Mon., Apr. 12, 6:00 PM
Recent initial public offerings in the Healthcare IPOs category.

Slide #1. Obalon Therapeutics, Inc. Initial Public Offering

Company: Obalon Therapeutics, Inc.
Proposed Symbol: OBLN
Shares Offered: 5,000,000
Price Per Share: $15.00
Over-Allotment: 750,000
Description: Obalon Therapeutics, Inc., a commercial-stage medical device company focused on developing and commercializing innovative medical devices to treat obese and overweight people by facilitating weight loss, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $15.00 per share. The shares are expected to begin trading on The NASDAQ Global Market on October 6, 2016 under the symbol "OBLN." In addition, the underwriters have been granted a 30-day option to purchase up to an additional 750,000 shares of common stock.

IPOs: Obalon Therapeutics, Inc.

List of Healthcare IPOs in this Slideshow: Company Ticker IPO Date Biocept, Inc. BIOC Genocea Biosciences, Inc. GNCA uniQure B.V. QURE Revance Therapeutics RVNC Eagle Pharmaceuticals EGRX Concert Pharmaceuticals CNCE Akebia Therapeutics AKBA Recro Pharma, Inc. REPH Phibro Animal Health Corporation PAHC Galmed Pharmaceuticals GLMD Ignyta RXDX Agile Therapeutics, Inc. AGRX MediWound Ltd MDWD SCYNEXIS SCYX Applied Genetic Technologies CorporationAGTC Phibro Animal Health Corporation PAHC Adamas Pharmaceuticals, Inc. ADMS Quotient Limited QTNT Aldeyra Therapeutics ALDX Radius Health, Inc. RDUS Zosano Pharma Corporation ZSAN Lantheus Holdings, Inc. LNTH Amphastar Pharmaceuticals, Inc. AMPH Adeptus Health, Inc. ADPT Karyopharm Therapeutics Inc. KPTI Affimed AFMD Minerva Neurosciences, Inc. NERV ReWalk Robotics Ltd. RWLK IRadimed Corporation IRMD SAGE Therapeutics, Inc SAGE Auris Medical Holding AG EARS Intersect ENT, Inc. XENT 7/24/2014 Ocular Therapeutix OCUL ContraFect Corporation CFRX VBL Therapeutics VBLT Catalent, Inc. CTLT Marinus Pharmaceuticals, Inc. MRNS T2 Biosystems, Inc. TTOO Cellectar Biosciences, Inc. CLRB ProQR Therapeutics PRQR Forward Pharma A/S FWP Calithera Biosciences, Inc. CALA Atara Biotherapeutics, Inc. ATRA Xenon Pharmaceuticals Inc. XENE Nevro NVRO Coherus BioSciences, Inc. CHRS Bellicum Pharmaceuticals, Inc. BLCM Second Sight Medical Products, Inc. EYES Check-Cap Ltd. CHEK 2/19/2015 Invitae Corporation NVTA Zosano Pharma Corporation ZSAN Ascendis Pharma A/S ASND Bellerophon Therapeutics BLPH OpGen OPGN Summit Therapeutics plc SMMT Blueprint Medicines Corporation BPMC Cellectis CLLS aTyr Pharma, Inc. LIFE Xbiotech XBIT Cidara Therapeutics, Inc. CDTX KemPharm, Inc. KMPH 4/16/2015 Viking Therapeutics, Inc. VKTX HTG Molecular Diagnostics HTGM Adaptimmune Therapeutics plc ADAP Collegium Pharmaceutical, Inc. COLL Glaukos Corporation GKOS Teladoc TDOC Glaukos Corporation GKOS Catabasis Pharmaceuticals CATB Seres Therapeutics, Inc. MCRB vTv Therapeutics Inc. VTVT Intec Pharma Ltd. NTEC Zynerba Pharmaceuticals, Inc. ZYNE Benitec Biopharma Limited BNTC REGENXBIO Inc. RGNX Penumbra, Inc. PEN Nabriva Therapeutics AG NBRV NovoCure Limited NVCR Aclaris Therapeutics, Inc. ACRS CytomX Therapeutics, Inc. CTMX WAVE Life Sciences Ltd. WVE Mesoblast Limited MESO BeiGene, Ltd. BGNE Editas Medicine, Inc. EDIT Syndax Pharmaceuticals, Inc. SNDX Corvus Pharmaceuticals, Inc. CRVS Aeglea BioTherapeutics, Inc. AGLE Intellia Therapeutics, Inc. NTLA Pulse Biosciences, Inc. PLSE Merus B.V. MRUS Reata Pharmaceuticals, Inc. RETA Clearside Biomedical, Inc. CLSD Selecta Biosciences, Inc. SELB Syros Pharmaceuticals SYRS Kadmon Holdings, Inc. KDMN Tactile Systems Technology, Inc. TCMD Cellect Biotechnology Ltd. APOP Medpace Holdings, Inc. MEDP Fulgent Genetics FLGT Obalon Therapeutics, Inc. OBLN

Healthcare IPOs Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.